XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Statements of Assets and Liabilities - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Investments at fair value:    
Investments at fair value [1] $ 350,758,810 $ 303,195,681
Cash 9,580,370 18,958,445
Interest receivable 4,382,953 2,873,029
Deferred financing cost 1,131,044 1,474,527
Paydown receivable 1,117,766 844,269
Prepaid expenses 43,343 0
Total assets 367,014,286 327,345,951
LIABILITIES    
Credit facility payable 160,000,000 153,000,000
Redemptions payable 4,696,330 0
Credit facility interest payable 2,965,907 2,283,546
Management fees payable, net of fee waivers (Note 6) 2,259,485 1,049,992
Incentive fees payable, net of fee waivers (Note 6) 1,428,394 0
Professional fees payable 415,679 195,076
Other payables 373,135 187,230
Reimbursement expense payable 148,280 35,877
Legal fees payable 60,491 26,377
Subscriptions received in advance 12,501 0
Distributions payable 0 4,351,080
Total liabilities 172,360,202 161,129,178
Commitments and contingencies (Note 11)
NET ASSETS    
Common shares, $0.001 par value (200,000,000 shares authorized, 7,470,032 and 6,592,546 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively) 7,470 6,593
Contribution Receivable (110,891) (110,891)
Additional paid-in capital 186,083,351 164,074,076
Accumulated undistributed (overdistributed) earnings 8,674,154 2,246,995
Total net assets $ 194,654,084 $ 166,216,773
Net asset value per share (in dollars per share) $ 26.06 $ 25.21
Non-controlled/Non-affiliated Investments [Member]    
Investments at fair value:    
Investments at fair value $ 349,560,695 $ 301,766,151
Controlled/Affiliate Investments [Member]    
Investments at fair value:    
Investments at fair value $ 1,198,115 $ 1,429,530
[1] Because there is no readily available market value for these investments, the fair value of each of these investments is determined in good faith using significant unobservable inputs by the Company’s board of directors (the “Board”) as required by the 1940 Act. See Note 4 “Fair Value Measurements” in the accompanying notes to the financial statements.